Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:56 UTC |
---|
HMDB ID | HMDB0015327 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Estramustine |
---|
Description | Estramustine is only found in individuals that have used or taken this drug. It is a nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. [PubChem]Estramustine is a derivative of estradiol with a nitrogen mustard moiety. This gives it alkylating properties. In vivo, the nitrogen mustard component is active and can alklyate DNA and other cellular components (such as tubulin components) of rapidly dividing cells. This causes DNA strandbreaks or misscoding events. This leads to apoptosis and cell death. Also, due to the drugs estrogen component, it can bind more selectively to active estrogen receptors. |
---|
Structure | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H] InChI=1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1 |
---|
Synonyms | Value | Source |
---|
17beta-Estradiol 3-(bis(2-chloroethyl)carbamate) | ChEBI | Estradiol 3-(N,N-bis(2-chloroethyl)carbamate) | ChEBI | Estramustina | ChEBI | Estramustinum | ChEBI | 17b-Estradiol 3-(bis(2-chloroethyl)carbamate) | Generator | 17b-Estradiol 3-(bis(2-chloroethyl)carbamic acid) | Generator | 17beta-Estradiol 3-(bis(2-chloroethyl)carbamic acid) | Generator | 17Β-estradiol 3-(bis(2-chloroethyl)carbamate) | Generator | 17Β-estradiol 3-(bis(2-chloroethyl)carbamic acid) | Generator | Estradiol 3-(N,N-bis(2-chloroethyl)carbamic acid) | Generator | Estramustin sodium phosphate | HMDB | Estramustine sodium phosphate | HMDB | Estracyt | HMDB | Estramustine phosphate sodium | HMDB | Phosphate, estramustin | HMDB | Leo 275 | HMDB | Emcyt | HMDB | Estramustinphosphate | HMDB | Estramustin phosphate | HMDB | Leo-275 | HMDB | Phosphate sodium, estramustine | HMDB |
| Show more...
---|
Chemical Formula | C23H31Cl2NO3 |
---|
Average Molecular Weight | 440.403 |
---|
Monoisotopic Molecular Weight | 439.168099277 |
---|
IUPAC Name | (1S,10R,11S,14S,15S)-14-hydroxy-15-methyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-trien-5-yl N,N-bis(2-chloroethyl)carbamate |
---|
Traditional Name | estramustine |
---|
CAS Registry Number | 2998-57-4 |
---|
SMILES | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H] |
---|
InChI Identifier | InChI=1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1 |
---|
InChI Key | FRPJXPJMRWBBIH-RBRWEJTLSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Estrane steroids |
---|
Direct Parent | Estrane steroids |
---|
Alternative Parents | |
---|
Substituents | - Estrane-skeleton
- Hydroxysteroid
- 17-hydroxysteroid
- Phenanthrene
- Tetralin
- Nitrogen mustard
- Benzenoid
- Cyclic alcohol
- Carbamic acid ester
- Secondary alcohol
- Carbonic acid derivative
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic oxide
- Alkyl chloride
- Alcohol
- Organic nitrogen compound
- Carbonyl group
- Organopnictogen compound
- Alkyl halide
- Organic oxygen compound
- Aromatic homopolycyclic compound
|
---|
Molecular Framework | Aromatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 104.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00038 g/L | Not Available | LogP | 5.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Estramustine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-7427900000-b87366cc1573c4f6c93a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Estramustine GC-MS (1 TMS) - 70eV, Positive | splash10-0006-8704900000-9a612e46f22fe81c874c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Estramustine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Estramustine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 10V, Positive-QTOF | splash10-006x-0720900000-7d95b1bd74a3e1ae6ae2 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 20V, Positive-QTOF | splash10-0a4l-2971100000-a6f224fc389435653942 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 40V, Positive-QTOF | splash10-03fu-9510000000-032d08f0be5c8b065fa7 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 10V, Negative-QTOF | splash10-000i-0522900000-a880e700fad8ec3373b9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 20V, Negative-QTOF | splash10-0v4i-0962500000-ffc041fb7d64ff64e5e8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 40V, Negative-QTOF | splash10-0h4o-7980000000-eef6a5c5a61126ea9699 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 10V, Positive-QTOF | splash10-0006-0020900000-c6017d6c0b19d376975c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 20V, Positive-QTOF | splash10-01vo-0216900000-e073983c6de9895bcdc7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 40V, Positive-QTOF | splash10-0bt9-5910000000-1c6900d7579dfbd1cc68 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 10V, Negative-QTOF | splash10-0019-4002900000-5c59bbd62d2862fbf52d | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 20V, Negative-QTOF | splash10-001i-9050000000-f5313068b0db56036aa5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Estramustine 40V, Negative-QTOF | splash10-001i-9000000000-c2fa753da65a4bac80a1 | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01196 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01196 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01196 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 227635 |
---|
KEGG Compound ID | C11228 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Estramustine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 259331 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 4868 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|